These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26595775)

  • 1. Semi-automated production of ⁸⁹Zr-oxalate/⁸⁹Zr-chloride and the potential of ⁸⁹Zr-chloride in radiopharmaceutical compounding.
    Lin M; Mukhopadhyay U; Waligorski GJ; Balatoni JA; González-Lepera C
    Appl Radiat Isot; 2016 Jan; 107():317-322. PubMed ID: 26595775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of zirconium-89 solution formulation on the efficiency of [
    Bubenshchikov V; Makichyan A; Larenkov A
    J Labelled Comp Radiopharm; 2022 Nov; 65(13):326-337. PubMed ID: 36138551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and Semi-Automated Processing of
    Gaja V; Cawthray J; Geyer CR; Fonge H
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32516930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully Automated
    Poot AJ; Adamzek KWA; Windhorst AD; Vosjan MJWD; Kropf S; Wester HJ; van Dongen GAMS; Vugts DJ
    J Nucl Med; 2019 May; 60(5):691-695. PubMed ID: 30530830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a chloride-based
    Graves SA; Kutyreff C; Barrett KE; Hernandez R; Ellison PA; Happel S; Aluicio-Sarduy E; Barnhart TE; Nickles RJ; Engle JW
    Nucl Med Biol; 2018; 64-65():1-7. PubMed ID: 30015090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem column isolation of zirconium-89 from cyclotron bombarded yttrium targets using an automated fluidic platform: Anion exchange to hydroxamate resin columns.
    O'Hara MJ; Murray NJ; Carter JC; Kellogg CM; Link JM
    J Chromatogr A; 2018 Sep; 1567():37-46. PubMed ID: 30054129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized methods for the production of high specific-activity zirconium-89.
    Holland JP; Sheh Y; Lewis JS
    Nucl Med Biol; 2009 Oct; 36(7):729-39. PubMed ID: 19720285
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
    Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of Zr-89 using sputtered yttrium coin targets
    Queern SL; Aweda TA; Massicano AVF; Clanton NA; El Sayed R; Sader JA; Zyuzin A; Lapi SE
    Nucl Med Biol; 2017 Jul; 50():11-16. PubMed ID: 28376350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized anion exchange column isolation of zirconium-89 (
    O'Hara MJ; Murray NJ; Carter JC; Morrison SS
    J Chromatogr A; 2018 Apr; 1545():48-58. PubMed ID: 29525125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution.
    Larenkov A; Bubenschikov V; Makichyan A; Zhukova M; Krasnoperova A; Kodina G
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31003494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of the next-generation positron nuclide zirconium-89 (
    Wang F; Ding J; Guo X; Liu T; Ding L; Xia L; Zhu H; Yang Z
    J Labelled Comp Radiopharm; 2021 Jan; 64(1):47-56. PubMed ID: 33067822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semi-automated system for concentration of rhenium-188 for radiopharmaceutical applications.
    Wunderlich G; Hartmann H; Andreeff M; Kotzerke J
    Appl Radiat Isot; 2008 Dec; 66(12):1876-80. PubMed ID: 18524608
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Pandya DN; Bhatt NB; Almaguel F; Rideout-Danner S; Gage HD; Solingapuram Sai KK; Wadas TJ
    J Nucl Med; 2019 May; 60(5):696-701. PubMed ID: 30442753
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent Advances in Zirconium-89 Chelator Development.
    Bhatt NB; Pandya DN; Wadas TJ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anion exchange and extraction chromatography tandem column isolation of zirconium-89 (
    O'Hara MJ; Carter JC; Kellogg CM; Link JM
    J Chromatogr A; 2022 Aug; 1678():463347. PubMed ID: 35908511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of "[
    Jolly D; Hopewell R; Kovacevic M; Li QY; Soucy JP; Kostikov A
    Appl Radiat Isot; 2017 Mar; 121():76-81. PubMed ID: 28038410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
    Mendler CT; Gehring T; Wester HJ; Schwaiger M; Skerra A
    J Nucl Med; 2015 Jul; 56(7):1112-8. PubMed ID: 25999431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.